Browsing Tag
OSR Holdings Inc.
2 posts
Why OSR Holdings (NASDAQ: OSRH) chose its scientific founder to lead Vaximm’s next immunotherapy chapter
OSR Holdings appoints scientific founder Dr. Andreas Niethammer as CEO of Vaximm AG to lead next-gen cancer immunotherapy strategy. Read more.
OSR Holdings completes merger, set to begin Nasdaq trading on February 18
OSR Holdings, Inc. has officially completed its business combination with OSR Holdings Co., Ltd., marking a pivotal milestone…